Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
A completed AstraZeneca-sponsored trial evaluated the validity of the Spanish version of the Subjective Well-being Under Neuroleptics Scale …
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis [Phase 3]
A Phase 3 clinical trial (FAST-A) evaluating the efficacy and safety of Quetiapin IR in acute psychosis was terminated.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Four Dimensions in Schizophrenia
Clinical Trial Update: Four Dimensions in Schizophrenia sponsored by AstraZeneca has completed, investigating schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
A completed clinical trial evaluating the safety and efficacy of switching outpatients with schizophrenia to quetiapine.
-
CLINICAL_TRIALS research · 2010-12-09Clinical Trial Update: A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)
A non-interventional study evaluating whether an SMS text service influenced adherence in patients treated with quetiapine (Seroquel) for bi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Efficacy Study on Cognitive Functions in Schizophrenic Patients [Phase 4]
A Phase 4 efficacy study evaluating cognitive functions in schizophrenia patients has completed, sponsored by Sanofi.
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
AstraZeneca-sponsored observational study evaluating efficacy and remission status in schizophrenia patients treated with an atypical antips…
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Subjective Well Being of Schizophrenic Patients in Greece
AstraZeneca-sponsored clinical trial in Greece assessing subjective well-being in schizophrenia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding escitalopram to ongoing treatment in treatment-resistant schizophrenia and schizo…
-
FDA approval · 2010-12-06FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for haloperidol submitted by Zydus Lifesciences Limited.
-
FDA approval · 2010-12-06FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., a generic antipsychotic, resulting in updated la…
-
FDA approval · 2010-12-06FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for trifluoperazine hydrochloride by Sandoz Inc. under an ANDA. This action updates the already-…
-
FDA approval · 2010-12-03FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., confirming approval of a gene…
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Fluphenazine decanoate by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2010-12-03FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE submitted by Actavis Pharma, Inc. (ANDA072062).
-
FDA approval · 2010-12-03FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for fluphenazine hydrochloride (generic) submitted by PAI Holdings, LLC dba PAI Pharma under AND…
-
FDA label_change · 2010-12-03FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride filed by PAI Holdings (PAI Pharma) to update the labeling.
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fluphenazine Decanoate from Fresenius Kabi USA, LLC, confirming approval of an additional produc…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia [Phase 3]
Phase 3 trial comparing long-acting injectable risperidone with placebo in schizophrenia reports effectiveness and safety data.
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Fluphenazine decanoate from Mylan Institutional LLC under an ANDA, allowing continued marketing …
-
FDA approval · 2010-12-03FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fluphenazine hydrochloride by Fresenius Kabi USA, LLC, signaling a regulatory action on this pro…
-
FDA approval · 2010-12-03FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for thioridazine hydrochloride submitted by Mylan Pharmaceuticals Inc., indicating a new or revised …
-
FDA approval · 2010-12-03FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, indicating an updated regulatory ac…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia [Phase 2, Phase 3]
This clinical trial update notes completion of Phase 2/Phase 3 study evaluating the efficacy and safety of intramuscular levosulpiride for a…